https://www.selleckchem.com/products/Eloxatin.html
Two datasets and other SRM measures were recommended as supplemental.Conclusion There is no one single measure that can be used to assess NBB dysfunction across all clinical research studies. Clinical and diagnostic tools are here recommended based on specific medical needs of the person with SCI/D. Following the CDE for SCI studies guidelines, we recommend both the SF-Qualiveen for bladder and the NBDS for bowel as relatively short measures with strong psychometrics. Other measures are also recommended. A combination of assessment too
Like
Comment
Share
